Quercetin benefits: what the studies show
Reviewed 34 sourcesPublished by PepVault
What quercetin does in human trials, as of November 2026: blood pressure, uric acid, allergy, exercise, COVID-19, the D+Q senolytic pair and drug interactions.

- Last reviewed
- Sources
- 34
- Questions
- 9
- Compounds
- 2
The short answer
Quercetin is a plant flavonol found in onions, apples, berries and tea. In people, its firmest result is blood pressure: pooled trials found it about 3 mmHg lower, mostly at 500 mg a day or more. It lowered uric acid in one trial and added about 2% to endurance. Its longevity fame comes from its pairing with dasatinib; alone, no published human trial has tested it as a senolytic.
Evidence: Human evidence is small to moderate: meta-analyses of short randomized trials for blood pressure and endurance, single trials for uric acid, strength and allergy, open-label COVID-19 trials, and senolytic data only with dasatinib; lifespan data are in mice.

What is quercetin?
Quercetin is a flavonol, one branch of the flavonoids, the pigment compounds plants make. It is the most common flavonol in the diet1, and onions, apples, berries and tea are its main food sources34. In plants it almost always comes with a sugar attached (a glycoside); the bare molecule without the sugar is called the aglycone, and that is what most capsules contain31.
In a dish, quercetin does a long list of things: it blocks the enzyme that makes uric acid, and it kills some senescent cells, the worn-out cells that pile up with age418. This page asks which survive in human trials, and how big each effect is.

How much quercetin does the body absorb?
Less than the label suggests, and the form decides how much. In a study of nine people with an ileostomy, whose gut empties before the colon (so nothing was lost to gut bacteria), about 52% of the quercetin in fried onions was absorbed, against 24% of the pure aglycone and 17% of rutin, the form in tea11. That share, the part of a dose that reaches the blood, is called bioavailability.
| Form (study) | Amount, as quercetin | Peak blood level | Time to peak |
|---|---|---|---|
| Onion extract (Graefe 2001)10 | 100 mg | 2.3 µg/mL | 0.7 hours |
| Quercetin-4'-glucoside (Graefe 2001)10 | 100 mg | 2.1 µg/mL | 0.7 hours |
| Buckwheat tea (Graefe 2001)10 | 200 mg | 0.6 µg/mL | 4.3 hours |
| Rutin (Graefe 2001)10 | 200 mg | 0.3 µg/mL | 7 hours |
| Lecithin form, Quercetin Phytosome (Riva 2019)12 | 500 mg tablet (about 200 mg), against 500 mg plain | About 20 times plain quercetin (223 against 11 ng/mL) | 3.4 against 4.8 hours |
The glucoside forms in onions reach the blood fast, at more than seven times rutin's peak from half the dose10. And what circulates is not quercetin itself: only its glucuronides, the forms the liver tags for removal, were found in plasma, with a half-life (the time for the level to fall by half) of about 11 hours10. The phytosome study was run by the maker's own scientists12, and the same form was used in the COVID-19 trials below. The two studies measured blood levels differently, so compare rows within one study only.
Does quercetin lower blood pressure?
Yes, by a few points, and this is quercetin's most repeated human result. A 2016 meta-analysis (a pooled analysis of trials) of 7 placebo-controlled trials and 587 people found systolic pressure 3.0 mmHg lower and diastolic 2.6 mmHg lower1. At 500 mg a day or more the systolic drop was 4.5 mmHg; below 500 mg it was not significant1. A 2020 update of 17 trials and 896 people found almost the same: 3.1 and 2.9 mmHg lower, with no change in cholesterol or blood sugar overall2.
The effect is largest where pressure is high. In a crossover trial, 730 mg a day for 28 days lowered pressure by 7/5 mmHg in people with stage 1 hypertension and did nothing in people with prehypertension3.
Quercetin is in PepVault's library. Add it to a protocol as an oral supplement and the app logs each day's capsule and can remind you at the time you set. Log it in PepVault
What else did quercetin do in human trials?
The human results, each dose the one the trial used:
| Outcome | Trial | Who | Trial dose | Result |
|---|---|---|---|---|
| Blood pressure | Meta-analysis, 20161 | 7 trials, 587 people | Mixed; split at 500 mg a day | Systolic −3.0, diastolic −2.6 mmHg |
| Blood pressure | Meta-analysis, 20202 | 17 trials, 896 people | Mixed | Systolic −3.1, diastolic −2.9 mmHg; lipids and glucose unchanged |
| Uric acid | Randomized crossover, 20164 | 22 men with high-normal uric acid | 500 mg a day, 4 weeks | Uric acid −26.5 µmol/L (about −0.45 mg/dL); glucose and blood pressure unchanged |
| Endurance | Meta-analysis, 20115 | 11 studies, 254 people | Median 1,000 mg a day, median 11 days | About 2% better than placebo: trivial to small |
| Colds | Randomized, placebo, 20106 | 1,002 adults | 500 or 1,000 mg a day, 12 weeks | No difference overall; in fit adults 40 and over on 1,000 mg, 31% fewer sick days |
| Strength | Randomized, placebo, 20257 | 26 older adults on a 6-week training plan | 200 mg a day of quercetin glycosides | Knee strength rose 15% against 5% on placebo; no extra muscle |
| Pollen allergy | Randomized, placebo, 20099 | 24 adults with cedar pollen allergy | 100 mg a day of a quercetin glycoside (EMIQ), 8 weeks | Eye symptom and medication score lower than placebo; nose symptoms no different |
The pattern: real effects, all small, most from one or two trials. The uric acid result fits quercetin's block on xanthine oxidase, the enzyme that makes uric acid4, but it is one four-week trial in 22 men, and no trial tested gout attacks. The allergy result came from a quercetin glycoside, and a second trial of 20 people found a benefit on eye symptoms too8.
Commonly reported: most people notice nothing day to day; the effects show up on a blood pressure cuff or a blood test. The trials reported few side effects, and those were mild31.
Does quercetin work for COVID-19?
The headline numbers are large and the trials behind them are weak. Two pooled analyses found fewer hospital admissions with quercetin, 70% fewer in one16 and an odds ratio of 0.25 in the other15. But the trials they pool are small and open-label, meaning patients and doctors knew who got quercetin, and two of the largest come from one group, using the phytosome form, with the maker's scientists among the authors1314.
The one double-blind trial since then asked a different question and found no effect. In a 2026 double-blind trial, 50 older or metabolically at-risk adults took a quercetin glycoside or placebo for four weeks before an mRNA booster, and antibody and T-cell responses were the same in both groups17. The treatment question waits for a blinded trial.
Is quercetin a senolytic on its own?
Not proven in people. A senolytic is a drug that kills senescent cells selectively. When the class was named in 2015, quercetin worked against senescent human blood-vessel cells in a dish and dasatinib, a leukemia drug, worked against senescent fat-cell precursors, so the two were paired as D+Q18. Every published human senolytic trial of quercetin has paired it with dasatinib. A randomized trial of quercetin alone in lung fibrosis, measuring senescence markers, is recruiting33.
Three small trials of the pair cut senescent cells in kidney disease19, improved walking in lung fibrosis without changing lung function20, and, against placebo, improved liver scarring21.
Our guide to fisetin and senolytics covers those trials, their doses and what is still running. The point for quercetin: none of these trials had a quercetin-only arm, so they cannot say what quercetin adds. Dasatinib is a prescription cancer drug; a D+Q course is a doctor's decision.
Why do mouse results look bigger than human ones?
| Claim | In mice or cells | In people |
|---|---|---|
| Endurance | 7 days of quercetin raised muscle mitochondria markers and running to exhaustion in mice23 | About 2% over placebo across 11 studies5 |
| Living longer | D+Q in old mice raised survival after treatment by 36%22 | No lifespan trial; tissue markers and a liver result only1921 |
| Viruses | Broad antiviral activity in cell culture6 | Open-label COVID-19 trials; no effect on vaccine response in a blinded one1317 |
| Blood pressure | Lowered in hypertensive rodents3 | About 3 mmHg in pooled trials12 |
Species note: the left column is mice or cells. A cell in a dish meets quercetin itself, not the glucuronides human blood carries10.
Does quercetin interact with medications?
Yes, and in both directions, which is what makes it hard to predict. Quercetin acts on P-glycoprotein (P-gp), a pump that pushes drugs out of gut cells, on OATP transporters that carry drugs into the liver, and on CYP3A4, the liver enzyme that clears many prescription drugs. In healthy volunteers (for cyclosporine, in animals) it raised some drug levels and lowered others:
| Drug (what it is) | Quercetin taken | Change in drug exposure |
|---|---|---|
| Fexofenadine (antihistamine; P-gp)24 | 500 mg three times a day, 7 days | Up 55% |
| Pravastatin (statin; OATP1B1)25 | 500 mg a day, 14 days | Up 24% |
| Midazolam (sedative; CYP3A)26 | 500 mg a day, 13 days | Down about 22%, in carriers of the CYP3A5*1 gene variant |
| Midazolam (sedative; CYP3A)27 | 1,500 mg a day, 1 week | Down 18%, not significant |
| Talinolol (beta blocker; P-gp)28 | 500 mg a day, 13 days | Down about 20% |
| Cyclosporine (transplant drug)29 | One dose with the drug, in pigs and rats | Down 56% in pigs and 43% in rats |
A published case adds blood thinners: a 79-year-old man stable on warfarin went from an INR of 2.5 to 7.5 within days of starting a capsule of 250 mg quercetin with 500 mg vitamin C, and back to 2.5 five days after stopping it30. The warfarin label asks for more frequent INR checks whenever a herbal product is started or stopped34. Drugs with a narrow margin between working and harming, such as warfarin and cyclosporine, are where a shift of this size matters2930. If you take one, whether quercetin fits is your prescriber's decision.
When to get help Unusual bruising, bleeding gums or dark stools while taking quercetin with a blood thinner is a reason to call your prescriber right away, as the warfarin label says34.
Is quercetin safe at supplement doses?
In the trials, yes: Germany's Federal Institute for Risk Assessment found adverse effects rarely reported and mild across the published human studies, but no adequate data for doses of 1,000 mg or more taken for longer than 12 weeks31. In animals, it flagged a possible worsening of an already damaged kidney and of estrogen-dependent tumours31. In people the kidney signal is from a different route: high-dose quercetin given into a vein to cancer patients caused kidney toxicity at the top doses32, which a capsule does not reproduce.
PepVault can remind you on the days you set and keeps each dose in the log, so the start date sits on record if your prescriber asks when a supplement began. Set reminders in PepVault
Sources
- Serban MC et al. Effects of quercetin on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2016. PubMed 27405810
- Huang H et al. Effect of quercetin supplementation on plasma lipid profiles, blood pressure, and glucose levels: a systematic review and meta-analysis. Nutr Rev. 2020. PubMed 31940027
- Edwards RL et al. Quercetin reduces blood pressure in hypertensive subjects. J Nutr. 2007. PubMed 17951477
- Shi Y, Williamson G. Quercetin lowers plasma uric acid in pre-hyperuricaemic males: a randomised, double-blinded, placebo-controlled, cross-over trial. Br J Nutr. 2016. PubMed 26785820
- Kressler J et al. Quercetin and endurance exercise capacity: a systematic review and meta-analysis. Med Sci Sports Exerc. 2011. PubMed 21606866
- Heinz SA et al. Quercetin supplementation and upper respiratory tract infection: a randomized community clinical trial. Pharmacol Res. 2010. PubMed 20478383
- Nishikawa T et al. Quercetin ingestion alters motor unit behavior and enhances improvement in muscle strength following resistance training in older adults: a randomized, double-blind, controlled trial. Eur J Nutr. 2025. PubMed 40063125
- Kawai M et al. Effect of enzymatically modified isoquercitrin, a flavonoid, on symptoms of Japanese cedar pollinosis: a randomized double-blind placebo-controlled trial. Int Arch Allergy Immunol. 2009. PubMed 19295240
- Hirano T et al. Preventative effect of a flavonoid, enzymatically modified isoquercitrin on ocular symptoms of Japanese cedar pollinosis. Allergol Int. 2009. PubMed 19454839
- Graefe EU et al. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol. 2001. PubMed 11361045
- Hollman PC et al. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr. 1995. PubMed 7491892
- Riva A et al. Improved oral absorption of quercetin from Quercetin Phytosome, a new delivery system based on food grade lecithin. Eur J Drug Metab Pharmacokinet. 2019. PubMed 30328058
- Di Pierro F et al. Possible therapeutic effects of adjuvant quercetin supplementation against early-stage COVID-19 infection: a prospective, randomized, controlled, and open-label study. Int J Gen Med. 2021. PubMed 34135619
- Di Pierro F et al. Quercetin as a possible complementary agent for early-stage COVID-19: concluding results of a randomized clinical trial. Front Pharmacol. 2023. PubMed 36712674
- Cheema HA et al. Quercetin for the treatment of COVID-19 patients: a systematic review and meta-analysis. Rev Med Virol. 2023. PubMed 36779438
- Ziaei S et al. The effect of quercetin supplementation on clinical outcomes in COVID-19 patients: a systematic review and meta-analysis. Food Sci Nutr. 2023. PubMed 38107099
- Takahama S et al. Immune preconditioning with oral quercetin supplement and COVID-19 mRNA vaccine responses: a randomized, double-blind, placebo-controlled trial. J Nutr. 2026. PubMed 41759822
- Zhu Y et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015. PubMed 25754370
- Hickson LJ et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease. EBioMedicine. 2019. PubMed 31542391
- Justice JN et al. Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study. EBioMedicine. 2019. PubMed 30616998
- Koning M et al. Senolytics dasatinib and quercetin in metabolic dysfunction-associated steatohepatitis: a proof-of-principle randomized, controlled trial. Nat Metab. 2026. PubMed 42823536
- Xu M et al. Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018. PubMed 29988130
- Davis JM et al. Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol. 2009. PubMed 19211721
- Kim KA et al. Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers. Eur J Clin Pharmacol. 2009. PubMed 19221726
- Wu LX et al. Inhibition of the organic anion-transporting polypeptide 1B1 by quercetin: an in vitro and in vivo assessment. Br J Clin Pharmacol. 2012. PubMed 22114872
- Duan KM et al. Effect of quercetin on CYP3A activity in Chinese healthy participants. J Clin Pharmacol. 2012. PubMed 21680781
- Nguyen MA et al. The influence of single-dose and short-term administration of quercetin on the pharmacokinetics of midazolam in humans. J Pharm Sci. 2015. PubMed 25988261
- Wang SY et al. Effect of quercetin on P-glycoprotein transport ability in Chinese healthy subjects. Eur J Clin Nutr. 2013. PubMed 23422925
- Hsiu SL et al. Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats. Life Sci. 2002. PubMed 12427482
- Patel R, Stine A, Zitko K. Enhanced anticoagulant effect of warfarin when co-administered with quercetin. J Pharm Technol. 2022. PubMed 36311308
- Andres S et al. Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food Res. 2018. PubMed 29127724
- Ferry DR et al. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res. 1996. PubMed 9816216
- ClinicalTrials.gov NCT07466420. Study on the efficacy of quercetin intake in patients with fibrotic interstitial lung disease (recruiting; sponsor Katerina M. Antoniou). clinicaltrials.gov
- Jantoven (warfarin sodium) tablets, prescribing information and Medication Guide. Upsher-Smith Laboratories. DailyMed, SPL version 14, November 2026. dailymed.nlm.nih.gov
Newsletter · Weekly
The weekly peptide briefing.
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.